Terms ending in 2028
Every in-force patent on Repligen Corporation's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,018,596 | Interactive Variable Pathlength Device In force · High confidence | Repligen Corporation | In force | High confidence | |
| US 8,390,814 | Interactive Variable Pathlength Device In force · High confidence | Repligen Corporation | In force | High confidence | |
| US 9,046,485 | Interactive Variable Pathlength Device In force · Medium confidence | Repligen Corporation | In force | Medium confidence | |
| US 9,939,373 | Interactive variable pathlength device In force · Medium confidence | Repligen Corporation | In force | Medium confidence | |
| US 10,876,961 | Interactive variable pathlength device In force · Medium confidence | Repligen Corporation | In force | Medium confidence | |
| US 7,691,608 | Nucleic Acids Encoding Recombinant Protein A In force · High confidence | Repligen Corporation | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.